As expected, both the mRNA and protein levels of FXRα and small heterodimer partner (SHP) were significantly elevated, along with the suppression of SREBP-1c and ChREBP, in BE-treated mice compared with those in mice in the HFD1 group (Figures 3G and 3H). The gene discussed is SREBF1; the disease is Barrett esophagus.